Resibufogenin Administration Prevents Oxidative Stress in a Rat Model of Human Preeclampsia

REFERENCES

• Pridjian G, Puschett JB. Preeclampsia, part I: Clinical and pathophysiological considerations. Obstet Gynecol Surv 2002; 57:598–618.
   PubMed Web of Science ®Google Scholar
• Pridjian G, Puschett JB. Preeclampsia, part II: Experimental and genetic considerations. Obstet Gynecol Surv 2002; 57:619–640.
   PubMed Web of Science ®Google Scholar
• Berg CJ, Atrash HK, Koonin LM, Tucker M. Pregnancy-related mortality in the United States, 1987–1990. Obstet Gynecol 1996; 88:161–167.
   PubMed Web of Science ®Google Scholar
• Roberts JM, Redman CWG. Pre-eclampsia: More than pregnancy-induced hypertension. Lancet 1993; 341:1447–1451.
   PubMed Web of Science ®Google Scholar
• Ianosi-Irimie M, Vu HV, Whitbred JM, A rat model of preeclampsia. Clin Exp Hypertens 2005; 27:605–617.
   PubMed Web of Science ®Google Scholar
• Vu HV, Ianosi-Irimie M, Pridjian CA, Involvement of marinobufagenin in a rat model of human preeclampsia. Am J Nephrol 2005; 25:520–528.
   PubMed Web of Science ®Google Scholar
• Uddin MN, Horvat D, Glaser SS, Mitchell BM, Puschett JB. Examination of the cellular mechanisms by which marinobufagenin inhibits cytotrophoblast function. J Biol Chem 2008; 283(26):17946–17953.
   PubMed Web of Science ®Google Scholar
• Uddin MN, Horvat D, Glaser SS, Marinobufagenin inhibits proliferation and migration of cytotrophoblast and CHO cells. Placenta 2008; 29:266–273.
   PubMed Web of Science ®Google Scholar
• LaMarca HL, Morris CA, Pettit GR, Nagowa T, Puschett JB. Marinobufagenin impairs first trimester cytotrophoblast differentiation. Placenta 2006; 27:984–988.
   PubMed Web of Science ®Google Scholar
• Uddin MN, McLean LB, Hunter FA, Vascular leak in a rat model of preeclampsia. Am J Nephrol 2009; 30:26–33.
   PubMed Web of Science ®Google Scholar
• Hays PM, Cruikshank DP, Dunn LJ. Plasma volume determination in normal and preeclamptic pregnancies. Obstet Gynecol 1985; 151:958–966.
   Web of Science ®Google Scholar
• Gallery EDM, Hunyor SN, Györy AZ. Plasma volume contraction: A significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy. Q J Med 1979; 48:593–602.
   PubMedGoogle Scholar
• Vu H, Ianosi-Irimie M, Danchuk S, Resibufogenin corrects hypertension in a rat model of human preeclampsia. Exp Biol Med 2006; 231:215–220.
   Web of Science ®Google Scholar
• Danchuk S, Sukhanov S, Horvat D, Uddin MN, Puschett JB. Effects of resibufogenin in experimental hypertension. Am J Nephrol 2008; 28:8–13.
   PubMed Web of Science ®Google Scholar
• Horvat D, Severson J, Uddin MN, Mitchell B, Puschett JB. Resibufogenin prevents the manifestations of preeclampsia in an animal model of the syndrome. Hypertens Pregnancy 2009; 25:1–9.
   Google Scholar
• Uddin MN, Agunanne E, Horvat D, Puschett JB. Alterations in the renin-angiotensin system in a rat model of preeclampsia. Am J Nephrol 2010; 31:171–177. DOI: 10.1159/000267099.
   PubMed Web of Science ®Google Scholar
• Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141–1148.
   PubMed Web of Science ®Google Scholar
• Romero JC, Reckelhoff JF. State-of-the-art lecture. Role of angiotensin and oxidative stress in essential hypertension. Hypertension 1999; 34:943–949.
   PubMed Web of Science ®Google Scholar
• Nickenig G, Harrison DG. The AT1-type angiotensin receptor in oxidative stress and atherogenesis, part I: Oxidative stress and atherogenesis. Circulation 2002; 105:393–396.
   PubMed Web of Science ®Google Scholar
• Wassmann S, Stumpf M, Strehlow K, Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 2004; 94:534–541.
   PubMed Web of Science ®Google Scholar
• Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004; 18:1791–1800.
   PubMed Web of Science ®Google Scholar
• Staff AC, Halvorsen B, Ranheim T, Henriksen T. Elevated level of free 8-iso-prostaglandin F2alpha in the decidua basalis of women with preeclampsia. Am J Obstet Gynecol 1999; 181:1211–1215.
   PubMed Web of Science ®Google Scholar
• Scott DE. Anemia in pregnancy. Obstet Gynecol Annu 1972; 1:219–244.
   PubMedGoogle Scholar
• Bagrov AY, Fedorova OV. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries. J Hypertens 1998; 16:1953–1958.
   PubMed Web of Science ®Google Scholar
• Fedorova OV, Agalakova NI, Talan MI, Lakatta EG, Bagrov AY. Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats. J Hypertens 2005; 23:1515–1523.
   PubMed Web of Science ®Google Scholar
• Puschett JB. The role of excessive volume expansion in the pathogenesis of preeclampsia. Med Hypotheses 2006; 67:1125–1132.
   PubMed Web of Science ®Google Scholar
• Morrow JD, Frei B, Longmire AW, Increase in circulating products of lipid peroxidation (F2-isoprostane) in smokers. N Engl J Med 1995; 332:1198–1203.
   PubMed Web of Science ®Google Scholar
• Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 1999; 33:424–428.
   PubMed Web of Science ®Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999; 222:222–235.
   PubMed Web of Science ®Google Scholar
• Walsh SW, Wang Y. Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metab 1995; 80:1888–1893.
   PubMed Web of Science ®Google Scholar
• Agunanne EE, Uddin MN, Horvat D, Puschett JB. Contribution of angiogenic factors in a rat model of preeclampsia. Am J Nephrol 2010; 32:332–339.
   PubMed Web of Science ®Google Scholar